Safety and efficacy of long‐term tofacitinib treatment in East Asian patients with ulcerative colitis in OCTAVE Open

BACKGROUND AND AIM: Tofacitinib is an oral small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We present safety and efficacy data from patients from East Asia (Japan, Korea, and Taiwan) in OCTAVE Open, an open‐label, long‐term extension study. METHODS: Patients in re...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuoka, Katsuyoshi, Hisamatsu, Tadakazu, Kim, Hyo Jong, Ye, Byong Duk, Arai, Shoko, Hoshi, Masato, Yuasa, Hirotoshi, Tabira, Junichi, Toyoizumi, Shigeyuki, Shi, Nanzhi, Woo, Joon‐suk, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles – Gastroenterology (Clinical)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796539/
https://www.ncbi.nlm.nih.gov/pubmed/35734858
http://dx.doi.org/10.1111/jgh.15923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796539/
https://www.ncbi.nlm.nih.gov/pubmed/35734858
http://dx.doi.org/10.1111/jgh.15923

Ejemplares similares